Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1993 Apr;217(4):338–346. doi: 10.1097/00000658-199304000-00005

Peptic ulcer surgery in patients with liver cirrhosis.

T Lehnert 1, C Herfarth 1
PMCID: PMC1242800  PMID: 8466308

Abstract

OBJECTIVE: This study identified risk factors of surgical treatment for gastroduodenal ulcer disease in patients with liver cirrhosis. SUMMARY BACKGROUND DATA: Liver cirrhosis is frequently associated with complicated peptic ulcer disease. Surgery in liver cirrhotics has a high mortality and morbidity especially when abdominal operations are performed. METHODS: Sixty-nine patients undergoing surgery for gastroduodenal ulcer disease between 1972 and 1991 were studied, retrospectively. RESULTS: Ninety percent of patients required emergency surgery for bleeding ulcer (n = 45) or perforation (n = 17). Mortality was 29% for elective patients (n = 7), 35% for patients with perforation and 64% for patients with bleeding. Overall mortality of 69 patients was 54%. Only 15 of 69 patients (22%) had an uncomplicated postoperative course. Postoperative bleeding, septic complications, and renal failure were the most frequent postoperative complications. Bleeding and multiple organ failure were the leading causes of death in 70% of patients. A univariate analysis determined preoperative hemoglobin < 12 g/L (p < 0.05), systolic blood pressure < 100 mm Hg (p < 0.025), prothrombin time < 60% (p < 0.05) and the presence of portal hypertension (p < 0.01) as prognostic factors. No significant correlation with survival could be established for excretory liver function (serum bilirubin) and partial thromboplastin time. CONCLUSIONS: To improve treatment results it is recommended (1) to substitute blood products (particularly coagulation factors) early and in sufficient quantities, (2) to diligently search for and to treat septic foci and administer antibiotics in a nonrestrictive manner, and (3) to restrict the operative procedure to the treatment required for control of the ulcer complication.

Full text

PDF
338

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abliazov A. A., Dudarev A. L., Iakovleva L. A. Skorost' évakuatsii zheludochnogo soderzhimogo u zdorovykh i bol'nykh liudei (radionuklidnoe issledovanie). Med Radiol (Mosk) 1991;36(4):18–20. [PubMed] [Google Scholar]
  2. Arakawa T., Satoh H., Fukuda T., Nakamura H., Kobayashi K. Endogenous prostaglandin E2 in gastric mucosa of patients with alcoholic cirrhosis and portal hypertension. Gastroenterology. 1987 Jul;93(1):135–140. doi: 10.1016/0016-5085(87)90325-8. [DOI] [PubMed] [Google Scholar]
  3. Aranha G. V., Greenlee H. B. Intra-abdominal surgery in patients with advanced cirrhosis. Arch Surg. 1986 Mar;121(3):275–277. doi: 10.1001/archsurg.1986.01400030029003. [DOI] [PubMed] [Google Scholar]
  4. Aranha G. V., Sontag S. J., Greenlee H. B. Cholecystectomy in cirrhotic patients: a formidable operation. Am J Surg. 1982 Jan;143(1):55–60. doi: 10.1016/0002-9610(82)90129-5. [DOI] [PubMed] [Google Scholar]
  5. Bonnevie O. Causes of death in duodenal and gastric ulcer. Gastroenterology. 1977 Nov;73(5):1000–1004. [PubMed] [Google Scholar]
  6. Branicki F. J., Coleman S. Y., Fok P. J., Pritchett C. J., Fan S. T., Lai E. C., Mok F. P., Cheung W. L., Lau P. W., Tuen H. H. Bleeding peptic ulcer: a prospective evaluation of risk factors for rebleeding and mortality. World J Surg. 1990 Mar-Apr;14(2):262–270. doi: 10.1007/BF01664889. [DOI] [PubMed] [Google Scholar]
  7. Brunner G. H., Lamberts R., Creutzfeldt W. Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine. Digestion. 1990;47 (Suppl 1):64–76. doi: 10.1159/000200520. [DOI] [PubMed] [Google Scholar]
  8. Di Mario F., Gottardello L., Burra P., Salvagnini M., Dalrì L., Leandro G., Contento F., Torri A., Naccarato R. Studio clinico-endoscopico sulla cicatrizzazione della lesione e sulla prevenzione delle recidive in pazienti con cirrosi epatica e malattia ulcerosa. G Clin Med. 1990 Apr;71(4):259-62, 265-6. [PubMed] [Google Scholar]
  9. Doberneck R. C., Sterling W. A., Jr, Allison D. C. Morbidity and mortality after operation in nonbleeding cirrhotic patients. Am J Surg. 1983 Sep;146(3):306–309. doi: 10.1016/0002-9610(83)90402-6. [DOI] [PubMed] [Google Scholar]
  10. Garrison R. N., Cryer H. M., Howard D. A., Polk H. C., Jr Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg. 1984 Jun;199(6):648–655. doi: 10.1097/00000658-198406000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gat U., Nekrasova E., Lancet D., Natochin M. Olfactory receptor proteins. Expression, characterization and partial purification. Eur J Biochem. 1994 Nov 1;225(3):1157–1168. doi: 10.1111/j.1432-1033.1994.1157b.x. [DOI] [PubMed] [Google Scholar]
  12. Giacobbe A., Facciorusso D., Conoscitore P., Spirito F., Nardella G. L., Cattani L., Lawson F. La malattia peptica nella cirrosi epatica. Minerva Dietol Gastroenterol. 1990 Oct-Dec;36(4):223–226. [PubMed] [Google Scholar]
  13. Herfarth C. Enzymologische Untersuchung zur Frage der postoperativen Leberschädigung. Bruns Beitr Klin Chir (1971) 1968 Oct;216(6):504–516. [PubMed] [Google Scholar]
  14. Hirohata T. Mortality from gastric cancer and other causes after medical or surgical treatment for gastric ulcer. J Natl Cancer Inst. 1968 Oct;41(4):895–908. [PubMed] [Google Scholar]
  15. IRVINE W. T., DUTHIE H. L., RITCHIE H. D., WATON N. G. The liver's role in histamine absorption from the alimentary tract; its possible importance in cirrhosis. Lancet. 1959 May 23;1(7082):1064–1069. doi: 10.1016/s0140-6736(59)90650-6. [DOI] [PubMed] [Google Scholar]
  16. Kim H., Park C., Jang W. I., Lee K. H., Kwon S. O., Robey-Cafferty S. S., Ro J. Y., Lee Y. B. The gastric juice urea and ammonia levels in patients with Campylobacter pylori. Am J Clin Pathol. 1990 Aug;94(2):187–191. doi: 10.1093/ajcp/94.2.187. [DOI] [PubMed] [Google Scholar]
  17. Kliems G., Feld W., von Bergmann K. Lebercirrhose und duodenogastrischer Reflux--Zum Problem des hepatogenen Ulcus. Langenbecks Arch Chir. 1983;360(2):109–118. doi: 10.1007/BF01254919. [DOI] [PubMed] [Google Scholar]
  18. Levi S., Beardshall K., Haddad G., Playford R., Ghosh P., Calam J. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet. 1989 May 27;1(8648):1167–1168. doi: 10.1016/s0140-6736(89)92752-9. [DOI] [PubMed] [Google Scholar]
  19. Metcalf A. M., Dozois R. R., Wolff B. G., Beart R. W., Jr The surgical risk of colectomy in patients with cirrhosis. Dis Colon Rectum. 1987 Jul;30(7):529–531. doi: 10.1007/BF02554783. [DOI] [PubMed] [Google Scholar]
  20. Mosnier H., Farges O., Vons C., Belghiti J., Fékété F. Gastroduodenal ulcer perforation in the patient with cirrhosis. Surg Gynecol Obstet. 1992 Apr;174(4):297–301. [PubMed] [Google Scholar]
  21. Otto G. F., Brückner W. L. Leberenzymmuster im Serum nach Magenoperationen. Med Klin. 1971 Nov 19;66(47):1603–1607. [PubMed] [Google Scholar]
  22. Palmer E. D. The vigorous diagnostic approach to upper-gastrointestinal tract hemorrhage. A 23-year prospective study of 1,4000 patients. JAMA. 1969 Feb 24;207(8):1477–1480. [PubMed] [Google Scholar]
  23. Rabinovitz M., Yoo Y. K., Schade R. R., Dindzans V. J., Van Thiel D. H., Gavaler J. S. Prevalence of endoscopic findings in 510 consecutive individuals with cirrhosis evaluated prospectively. Dig Dis Sci. 1990 Jun;35(6):705–710. doi: 10.1007/BF01540171. [DOI] [PubMed] [Google Scholar]
  24. Ross A. H., Smith M. A., Anderson J. R., Small W. P. Late mortality after surgery for peptic ulcer. N Engl J Med. 1982 Aug 26;307(9):519–522. doi: 10.1056/NEJM198208263070902. [DOI] [PubMed] [Google Scholar]
  25. Sarosiek J., Bilski J., Murty V. L., Slomiany A., Slomiany B. L. Colloidal bismuth subcitrate (De-Nol) inhibits degradation of gastric mucus by Campylobacter pylori protease. Am J Gastroenterol. 1989 May;84(5):506–510. [PubMed] [Google Scholar]
  26. Sato T., Imamura M., Sasaki I., Ohneda A. Gastric acid secretion and gastrin and gastric inhibitory polypeptide release in cirrhotic patients. Am J Gastroenterol. 1985 Mar;80(3):163–169. [PubMed] [Google Scholar]
  27. Schwartz S. I. Biliary tract surgery and cirrhosis: a critical combination. Surgery. 1981 Oct;90(4):577–583. [PubMed] [Google Scholar]
  28. Seitz W., Rothmund M., Kraushaar G. Die chirurgische behandlung des Gastroduodenalulcus beim alten Menschen. Langenbecks Arch Chir. 1982;356(2):95–103. doi: 10.1007/BF01239457. [DOI] [PubMed] [Google Scholar]
  29. Sidebotham R. L., Baron J. H. Hypothesis: Helicobacter pylori, urease, mucus, and gastric ulcer. Lancet. 1990 Jan 27;335(8683):193–195. doi: 10.1016/0140-6736(90)90279-e. [DOI] [PubMed] [Google Scholar]
  30. Sirinek K. R., Burk R. R., Brown M., Levine B. A. Improving survival in patients with cirrhosis undergoing major abdominal operations. Arch Surg. 1987 Mar;122(3):271–273. doi: 10.1001/archsurg.1987.01400150025003. [DOI] [PubMed] [Google Scholar]
  31. Smoot D. T., Mobley H. L., Chippendale G. R., Lewison J. F., Resau J. H. Helicobacter pylori urease activity is toxic to human gastric epithelial cells. Infect Immun. 1990 Jun;58(6):1992–1994. doi: 10.1128/iai.58.6.1992-1994.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sonnenberg A. Concordant occurrence of gastric and hypertensive diseases. Gastroenterology. 1988 Jul;95(1):42–48. doi: 10.1016/0016-5085(88)90288-0. [DOI] [PubMed] [Google Scholar]
  33. Stopik D., Hampel K. E., Kleist D. v. Endogenes Plasma-Histamin und "hepatogenes" gastroduodenales Ulkus bei Leberzirrhose. Dtsch Med Wochenschr. 1977 Jun 24;102(25):932–933. doi: 10.1055/s-0028-1104991. [DOI] [PubMed] [Google Scholar]
  34. Tanaka M., Inatsuchi S., Terasaki T., Funaki J., Bandou T., Shimada K., Wakabayashi H., Kubota Y., Watanabe A. Duodenal mucosal hemodynamics in patients with liver cirrhosis. Acta Med Okayama. 1990 Oct;44(5):273–277. doi: 10.18926/AMO/30446. [DOI] [PubMed] [Google Scholar]
  35. Terés J., Bordas J. M., Bru C., Diaz F., Bruguera M., Rodes J. Upper gastrointestinal bleeding in cirrhosis: clinical and endoscopic correlations. Gut. 1976 Jan;17(1):37–40. doi: 10.1136/gut.17.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Tinkoff G., Rhodes M., Diamond D., Lucke J. Cirrhosis in the trauma victim. Effect on mortality rates. Ann Surg. 1990 Feb;211(2):172–177. doi: 10.1097/00000658-199002000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Walker S., Krishna D. R., Klotz U., Bode J. C. Frequent non-response to histamine H2-receptor antagonists in cirrhotics. Gut. 1989 Aug;30(8):1105–1109. doi: 10.1136/gut.30.8.1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wara P., Berg V., Amdrup E. Factors influencing mortality in patients with bleeding ulcer. Review of 7 years' experience preceding therapeutic endoscopy. Acta Chir Scand. 1983;149(8):775–785. [PubMed] [Google Scholar]
  39. Watt P. C., Patterson C. C., Kennedy T. L. Late mortality after vagotomy and drainage for duodenal ulcer. Br Med J (Clin Res Ed) 1984 May 5;288(6427):1335–1338. doi: 10.1136/bmj.288.6427.1335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Weiler H., Weiler C., Gerok W. Gastric mucosal prostaglandin E2 levels in cirrhosis and portal hypertension. J Hepatol. 1990 Jul;11(1):58–64. doi: 10.1016/0168-8278(90)90272-s. [DOI] [PubMed] [Google Scholar]
  41. Zarski J. P., Bichard P., Bourbon P., Tournery A., Demongeot J., Rachail M. La chirurgie digestive extra-hépatique chez le cirrhotique: mortalité, morbidité, facteurs pronostiques pré-opératoires. Gastroenterol Clin Biol. 1988 Jan;12(1):43–47. [PubMed] [Google Scholar]
  42. Zittel R. X., Weyand H., Weyand F. Zur Bedeutung pathologischer Leberbefunde beim Magen-Duodenal-Ulkus und beim Ulcus pepticum jejuni. Dtsch Med Wochenschr. 1967 Apr 28;92(17):791–793. doi: 10.1055/s-0028-1103771. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES